Antibodies that specifically bind to api5 protein
AssigneeNex-I, Inc.
InventorsKyoung Wan YOON, Kyungjin BOO, Jeongmin RYOO, Jinyoung SOHN, Junho YEOM, Sujin KIM
Life of this patent
Estimating the term…
Loading patent…
AssigneeNex-I, Inc.
InventorsKyoung Wan YOON, Kyungjin BOO, Jeongmin RYOO, Jinyoung SOHN, Junho YEOM, Sujin KIM
Estimating the term…
The present invention relates to an antibody specifically binding to apoptosis inhibitor 5 (API5) protein and uses thereof. The antibody or antigen-binding fragment thereof that specifically binds to APIS according to the present invention can have excellent anticancer effects, such as inhibiting phosphorylation of ERK in cancer cells and inhibiting cancer growth. In addition, the antibody or antigen-binding fragment thereof exhibits excellent anticancer effects against cancers that are resistant or refractory to anticancer drugs. Accordingly, it is useful for preventing or treating cancers resistant or refractory to anticancer drugs as well as general cancers.
An antibody or antigen-binding fragment thereof that specifically binds to apoptosis inhibitor 5 (API5) comprising:
Dependencies are inferred from the claim text.